Plasma D‐dimer and interleukin‐6 are associated with treatment response and progression‐free survival in advanced NSCLC patients on anti‐PD‐1 therapy
Abstract Background/Aims Response to therapy after using immune checkpoint inhibitors (ICIs) is unpredictable due to significant interindividual variation in efficacy among advanced non‐small cell lung cancer (NSCLC) patients. The current study centered on the identification of perivascular blood bi...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley
2023-08-01
|
| シリーズ: | Cancer Medicine |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1002/cam4.6222 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|